Oral Thrush Market Growth Overview Along with Company Profiles by Type and Treatment Details, Competitors Analysis like Bayer AG, Stellar Pharma, Pfizer Inc. and Forecast 2023

Oral thrush also called as oral candidiasis is an infection of the mouth caused by strains of the Candida species. Candida albicans is the most commonly implicated organism, which occurs naturally in about 50% of the world's population as a normal component of the oral microbiota. However, Candida albicans is an opportunistic pathogen and it accounts for about 50% of oral candidiasis cases across the globeand other strains of candida such as C. tropicalis, C. glabrata and C. albicans, account for over 80% of cases collectively. Increasing prevalence of HIV has increased immunodeficiency in the patient, which makes the patient more susceptible to dubliniensis and C. geotrichium. Furthermore, the infection is also detected in hospitalized patients, smokers, immune-compromised individuals due to diseases such as diabetes, cancer, and Down syndrome.

Click to Get Sample Report @ https://www.marketresearchfuture.com/sample_request/4417 .

Oral thrush (oral candidiasis) is a medical condition in which the fungus, Candida albicans, over-grows on the lining of the mouth. The global oral thrush (oral candidiasis) market is growing with the sound pace. According to a recent study report published by the Market Research Future, global oral thrush market is booming and expected to gain prominence over the forecast period. The global oral thrush market is expected to reach USD 9.5 billion by 2023, and the market is projected to grow at a CAGR of ~ 4.4 % during the forecast period 2017-2023.

Global Oral Thrush Market - Key Players

Some of key players profiled in the report are Bayer AG, Teva Pharmaceuticals, Stellar Pharma, Pfizer Inc., Wockhardt Ltd., Ranbaxy Laboratories Limited, Bristol Laboratories, Glenmark Pharmaceuticals, GlaxoSmithKline Plc., and others.

Global Oral Thrush Market - Competitive Analysis

Characterized by the presence of several well-established and small players, the oral thrush market appears to be highly competitive and fragmented. International players are increasingly expanding their footprint in the developing economy, making it difficult for regional vendors to compete with them, especially in terms of features such as product differentiation, product portfolios, quality, and pricing. The market is witnessing intensified competition which is expected to get more intensified further during the forecast period. The intense competition prevalent in the market dictates the consolidation among marketers.

Pfizer Inc. is one of the major players of the global oral thrush market. The company is headquartered in the U.S. and shares a repute of a leading research-based biopharmaceutical company. The company’s total revenue increased from USD 48,851 million in 2015 to USD 52,824 million in 2016. This was marked by the significant amount of its revenue being spent on the R&D. In 2016, the company spent 14.9% of its total revenue in research and development which made the company to improve its product portfolio and launch new product, strengthening its position in the market.

In August 2016, FDA approved Pfizer's TROXYCA ER extended-release capsules CII for pain management.

In October 2016, Teva Pharmaceutical Industries Ltd. acquired Anda, Inc., a leading distributor of generic pharmaceuticals in the U.S., from Allergan plc.

In July 2017, Glenmark Pharmaceuticals was granted the final approval by the MHRA (Medicines and Healthcare products Regulatory Agency) for Maloff Protect which is an anti-malarial medication in the United Kingdom.

Bayer AG, Teva Pharmaceuticals, Stellar Pharma, Pfizer Inc., Wockhardt Ltd., Ranbaxy Laboratories Limited, Bristol Laboratories, Glenmark Pharmaceuticals, and GlaxoSmithKline Plc. are some of the prominent players at the forefront of competition in the global oral thrush market and are profiled in the MRFR Analysis.

Get Unbelievable Discount on Report @ https://www.marketresearchfuture.com/check-discount/4417 .

Global Oral Thrush Market - Regional Analysis

North America leads the market owing to well-developed healthcare infrastructure and rising per capita healthcare expenditure. Europe holds the second largest market share. Increasing funding for research and huge patient population within the region facilitates the market growth. Asia Pacific is emerging as the fastest region for the market growth during the forecast period due to the presence of the developed economies like India and China within the region. According to the Indian Brand Equity Foundation in 2017, Indian healthcare sector is one of the fastest growing industries which is expected to advance at a CAGR of 22.87% during 2015-20 and reach USD 280 billion by 2020. On the other hand, Middle East and Africa holds the least market share, especially in the African region due to the stringent government policies and low per capita income. On the other hand, Middle East leads the market of the Middle East & Africa region, due to the presence of developed economies like Kuwait and Qatar along with huge healthcare expenditure.

Global Oral Thrush Market – Segments

The global oral thrush market has been segmented on the basis of type, diagnosis, treatment, and end user.

Based on type, the market has been segmented as pseudomembranous, erythematous, hyperplastic, and others.

Based on diagnosis, the market has been segmented as examination, biopsy, endoscopy, and others.

Based on treatment, the market has been segmented as anti-fungal, immune-modulators, and others.

Based on the end user, the market has been segmented as hospitals & clinics, academic and research, and others.

Major Table of Content

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

Continued….

To Know More Enquire @ https://www.marketresearchfuture.com/enquiry/4417 .

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: salesteam@marketresearchfuture.com

This release was published on openPR.